Navigation Links
MedQuist Reports Third Quarter 2008 Results
Date:11/4/2008

MOUNT LAUREL, N.J., Nov. 4 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), the largest Medical Transcription Service Organization (MTSO) in the world, today announced its results for the quarter ended September 30, 2008.

Net revenues for the third quarter of 2008 were $81.3 million compared with $82.5 million in the third quarter of 2007. The decrease in net revenues of $1.2 million or 1% from the prior year period was driven primarily by lower average pricing.

The operating loss for the quarter improved to a loss of $5.3 million compared to an operating loss of $10.3 million in the third quarter of 2007. The current period operating loss includes a charge of $5.9 million related to a tentative settlement of the Department of Justice's (DOJ) investigation of the company. The DOJ and the company have reached a tentative agreement to settle the DOJ's civil investigation for a payment of $6.8 million of which $0.9 million was previously recorded. Non-GAAP operating income (excluding the cost of investigation and legal proceedings, net) improved by $7.8 million to a profit of $1.9 million in the third quarter of 2008 compared to a non-GAAP operating loss of $5.9 million in the third quarter of 2007.

Cost of revenues were reduced by $7.1 million or 11% to $57.2 million in the third quarter of 2008 compared to $64.3 million in the third quarter of 2007. This resulted in a decrease in cost of revenues as a percentage of net revenues to 70% compared to 78% in the third quarter of 2007.

Selling general and administrative expenses declined $2.4 million or 15% to $13.1 million in the third quarter of 2008 compared to $15.5 million in the third quarter of 2007. This decline primarily reflects the benefits of the re
'/>"/>

SOURCE MedQuist Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. MedQuist Reports Second Quarter 2008 Results
2. MedQuist Announces Changes to Board of Directors
3. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
4. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
5. MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
6. MedQuist to Get New Majority Stakeholder
7. MedQuist Technology Solutions to Power Documentation Workflow at New England Facility
8. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
9. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
10. MedQuist Announces Appointment of Brian ODonoghue and Mark E. Schwarz to its Board of Directors
11. MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia entrepreneur ... is still strongly maintaining her firm’s success in the hair care and distribution ... upcoming city-to-city tour, Ellis will be providing “Look and learn” live demonstrations, as ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... ranked a top-five hospital by U.S. News & World Report, to provide breaking ... , Editorial and marketing groups within OncLive, which provides oncologists resources and ...
(Date:9/1/2015)... ... 01, 2015 , ... The Jerry Segal Classic to benefit the patients of ... Country Club in Lafayette Hill, PA. Over the past 26 years, the Classic, organized ... and services designed to support patients and their families during their time at Magee ...
(Date:9/1/2015)... , ... September 01, 2015 , ... With former IBMers ... and Math) disciplines since its inception more than 35 years ago. A pilot program ... and their teachers - and, not just those intent on pursuing careers in these ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... announced the release of version 5.2 of the FirstSpirit Content Management System with ... initiative. With the new version of FirstSpirit, companies will be well on their ...
Breaking Medicine News(10 mins):Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3
... funded by Project A.L.S. and appearing in today's advance ... cells may provide a new tool for studying disease ... known as Lou Gehrig's disease. ,Both studies ... with the Project A.L.S./Jenifer Estess Laboratory for Stem Cell ...
... disability and reduces relapse rates in multiple sclerosis (MS) has ... relapsing MS. //Vision loss is one of the most common ... the April 17, 2007, issue of Neurology?, the scientific journal ... were performed on data from the AFFIRM and SENTINEL studies, ...
... to have limited benefit in the first-line treatment of ... a report in the April issue of Archives of ... report in the same issue finds that a cream ... patients with another ulcer-causing mouth disease, oral erosive lichen ...
... concern over the potential impact of global warming has ... US professor developing an environmental observation system// for India. ... and economic development at Louisiana State University, recently joined ... of the countries facing the most dramatic consequences of ...
... fratricides in the armed forces, Defence Minister A.K. Antony Monday ... ,"The number of suicide and fratricide cases continues to be ... said while addressing the five-day Army Commanders' Conference here. ... in 2006. There have been 21 cases this year alone. ...
... drug already used for high blood pressure and prostate ... nightmares in veterans with posttraumatic stress disorder (PTSD). ... has been demonstrated effective for PTSD nightmares and sleep ... the mental health service at the Veterans Affairs Puget ...
Cached Medicine News:Health News:Stem Cells Provide New Tool for Studying Disease and Identifying ALS Drugs 2Health News:MS Drug Helps Reduce Vision Loss 2Health News:Clinical Studies Evaluate Potential Treatments for Mouth Ulcers 2Health News:Clinical Studies Evaluate Potential Treatments for Mouth Ulcers 3Health News:US Professor Helping India Deal With Global Warming 2Health News:Antony Concerned Over Growing Suicide Rates in Armed Forces 2Health News:BP and Prostate Problems Drug Effective in Treating PTSD Nightmares 2Health News:BP and Prostate Problems Drug Effective in Treating PTSD Nightmares 3
(Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
(Date:9/1/2015)... , Sept. 1, 2015  Dr. Cindy ... Labs , the cannabis testing subsidiary of DigiPath, Inc. ... Group about the lack of consistency in today,s ... online resource for medical cannabis information, she explained that ... because their lack of uniform requirements makes standardization impossible. ...
(Date:9/1/2015)... 1, 2015   Alpha Imaging LLC , a leading distributor ... announced today that they have been awarded exclusive rights to ... in Michigan.   The new territory supplements Alpha Imaging,s existing Shimadzu sales ... Ohio , Indiana , ... , West Virginia , Delaware ...
Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Alpha Imaging Expands Shimadzu Territory 2
... Medical Systems (NYSE: VAR ) today announced that ... N.A. to repurchase $250 million of its common stock under ... revolving credit facility with Bank of America, N.A. to increase ... Under the accelerated repurchase agreement, Varian will pay $250 ...
... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced ... trial evaluating the safety and pharmacokinetics of dabigatran ... valves.(1) The 12-week study will compare three doses ... 300mg bid) to warfarin in patients with both ...
Cached Medicine Technology:Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 2Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 7
... the newest and most advanced automated immunoassay ... AIA-1800 launches with a full menu of ... reproductive, cardiac, and anemia assays. ,The AIA-1800 ... primary tube sampling, auto dilution, auto pretreatment, ...
EZ-PSA is a one-step immunoassay for the rapid, qualitative determination of human Prostate Specific Antigen (PSA) in whole blood. The test is intended for professional use as an aid in the diagnosis...
... name from its first known site of ... of PSA circulates bound to anti-chymotrypsin (PSA-ACT) ... PSA are elevated in patients with prostate ... [1-3]. In addition, PSA serum levels appear ...
... Functional Vision, Quality of Vision and ... both target illumination and glare luminance ... results. Day/Night testing with/without glare and ... and all ANSI standards. All Light ...
Medicine Products: